Value of Brush Border Cytology for Dominant Strictures in Primary Sclerosing Cholangitis

References

• 1 Broome U, Olsson R, Lööf L, et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.  Gut. 1996;  38 610-5
• 2 Tamada K, Ueno N, Tomiyama T, et al. Characterization of biliary strictures using intraductal ultrasonography: comparison with percutaneous cholangioscopic biopsy.  Gastrointest Endosc. 1998;  47 341-9
• 3 Dahlerup J F, Keiding S, Hansen S B, et al. Detection of cholangiocarcinoma in patients with primary sclerosing cholangitis by positron emission tomography (abstract).  Digestion. 1998;  59 (Suppl. 3) 26
• 4 Ponsioen C IJ, Vrouenraets S ME, van Milligen de Wit A WM, et al. Value of brush border cytology for dominant strictures in primary sclerosing cholangitis.  Endoscopy. 1999;  31 305-9
• 5 Rizzi P M, Portman B, Ramage J K, et al. p53 protein overexpression in cholangiocarcinoma arising in primary sclerosing cholangitis.  Gut. 1996;  38 265-8
• 6 Hultcrantz R, Olson R, Danielson A, et al. J Hepatol 1999 30: 669-73
• 7 Luftus E V, Aguilar H J, Sandborn W, et al. Risk of colorectal neoplasia in patients with primary biliary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation.  Hepatology. 1998;  27 685-90
• 8 Lindor K D, Mayo PSC/UDCA Study Group. Ursodiol for the treatment of primary sclerosing cholangitis.  N Engl J Med. 1997;  336 691-5
• 9 Stiehl A, Rudolph G, Sauer P, et al. Efficacy of ursodeoxycholic acid and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis: an 8-year prospective study.  J Hepatol. 1997;  26 560-6